Comment by
Johnandrose22 on Oct 30, 2020 10:36am
Thank you for your typically candid and insightful post, especially your not so subtle inference regarding the “mistake” made in Phase 2 dosimetry. I continue to find it difficult to believe it was a mistake. OK...I said it...again. John
Comment by
Hankerchief on Oct 30, 2020 11:01am
Theralase is possibly bordering on a highly effective therapeutic option for cancer/infection that could benefit millions of people and it's like they are running in mud IMO. WTH? Get your act together and get on with it FFS.....IMO and again IMO as RR would say.
Comment by
CAinPlap on Oct 30, 2020 3:09pm
Hachet or Hachey job? ;) To be fair, doubt trial "misstake" was her fault. It is Dr. K's loyalty we need to question given his involvement with much larger, deeper pocketed companies.
Comment by
Eoganacht on Oct 30, 2020 4:32pm
It is not a question of loyalty. It's a question of integrity. I believe Dr. Kulkarni will go with the solution which is most beneficial for cancer patients. If he put patient's lives at risk to make a few extra dollars he would not be a doctor. Just another dirty moneygrubber.
Comment by
enriquesuave on Oct 30, 2020 5:02pm
I totally agree there Eoganacht. We don't know how or why this bladder volume error occurred, but it definitely set the protocol straight once and for all. It will ensure that no Urologist ever makes that mistake again as we now know one cannot compromise on bladder volume regardless of green light intensity.IMO
Comment by
fredgoodwinson on Oct 30, 2020 12:45pm
Seems that you may have an agenda here too Tom - or is just (yuk) 'Gadgie'?
Comment by
fredgoodwinson on Oct 30, 2020 12:49pm
Tom I may have nmisinterpreted your post (it`s not difficult!) - if you weren`t personally insulting me please accept apologies for the response.
Comment by
menoalittle on Oct 30, 2020 8:56pm
>> I continue to find it difficult to believe it was a mistake. moi aussi